A Long Term Study of Ambrisentan in Pulmonary Arterial Hypertension Subjects Having Completed AMB-320 (NCT00423748) or AMB-321 (NCT00423202)

Clinical trial NCT00578786 · COMPLETED

Trial details

NCT number: NCT00578786
Sponsor: Gilead Sciences
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Pulmonary Arterial Hypertension

Start date: 2004-02-01
Primary completion: 2010-03-01
Enrollment: 383

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.